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ABSTRACT
The 39 ends of most eukaryotic pre-mRNAs are generated by 39 endonucleolytic cleavage and subsequent polyad-
enylation. 39-end formation can be influenced positively or negatively by various factors. In particular, U1 snRNP acts
as an inhibitor when bound to a 59 splice site located either upstream of the 39-end formation signals of bovine
papilloma virus (BPV) late transcripts or downstream of the 39-end processing signals in the 59 LTR of the HIV-1
provirus. Previous work showed that in BPV it is not the first step, 39 cleavage, that is affected by U1 snRNP, but rather
the second step, polyadenylation, that is inhibited. Since in HIV-1 the biological requirement is to produce transcripts
that read through the 59 LTR cleavage site rather than being cleaved there, this mechanism seemed unlikely to apply.
The obvious difference between the two examples was the relative orientation of the 39-end formation signals and the
U1 snRNP-binding site. In vitro assays were therefore used to assess the effect of U1 snRNP bound at various
locations relative to a cleavage/polyadenylation site on the 39 cleavage reaction. U1 snRNP was found to inhibit
cleavage when bound to a 59 splice site downstream of the cleavage/polyadenylation site, as in the HIV-1 LTR. U1
snRNP binding at this location was shown not to affect the recruitment of multiple cleavage/polyadenylation factors
to the cleavage substrate, indicating that inhibition is unlikely to be due to steric hindrance. Interactions between U1A,
U1 70K, and poly(A) polymerase, which mediate the effect of U1 snRNP on polyadenylation of other pre-mRNAs, were
shown not to be required for cleavage inhibition. Therefore, U1 snRNP bound to a 59 splice site can inhibit cleavage
and polyadenylation in two mechanistically different ways depending on whether the 59 splice site is located upstream
or downstream of the cleavage site.
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INTRODUCTION
Newly synthesized eukaryotic mRNA precursors have
to be released from their site of transcription, pro-
cessed by removal of intervening sequences, and pro-
tected from exonucleolytic degradation before they can
be transported to the cytoplasm and translated there+
All these posttranscriptional steps are influenced by
the proper acquisition of the mRNA 39 end+ Most pre-
mRNAs acquire a poly(A) tail at their 39 end by cleav-
age and polyadenylation+ This process occurs in two
steps, an endonucleolytic cleavage of the RNA fol-
lowed by the addition of the poly(A) tail+ The RNA se-
quences that determine the precise position of cleavage
in metazoa are a highly conserved AAUAAA hexanu-
cleotide found upstream of the cleavage site and a
more variable GU-rich sequence found downstream+
Although simple in principle, 39-end processing of
pre-mRNAs requires a surprisingly large number of pro-
teins (Colgan & Manley, 1997; Wahle & Rüegsegger,
1999)+ The cleavage and polyadenylation specificity
factor (CPSF) is a tetrameric complex whose 160-kDa
subunit binds directly to the AAUAAA sequence+ The
160-kDa subunit of CPSF interacts with the 77-kDa
subunit of CstF (cleavage stimulation factor), a trimeric
factor that binds to the GU-rich sequence via its 64-kDa
subunit+ CPSF and CstF bind to pre-mRNAs coopera-
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tively+ Poly(A) polymerase (PAP) is the enzyme that
generates the poly(A) tail and is recruited to the RNA
via its interaction with CPSF-160+ PAP is also required
for the cleavage step on certain pre-mRNA substrates+
Finally, two cleavage factors, CF Im and CF IIm, are
essential for cleavage+ Whereas CF IIm is poorly char-
acterized, CF Im has been purified to homogeneity, and
cDNAs encoding for two of its subunits have been iso-
lated+ CF Im appears to act at a very early step in the
reaction and may help in the recruitment of additional
cleavage factors+ After cleavage has occurred, the first
phase of addition of the poly(A) tail requires only CPSF
and PAP+ Once 10–15 A residues have been added,
poly(A) binding protein II binds to the short A stretch
and supports processive synthesis of the remaining
residues of the poly(A) tail (Colgan & Manley, 1997;
Wahle & Rüegsegger, 1999)+
Recent evidence indicates that the cleavage/poly-
adenylation factors do more than participate in 39-end
processing+ Mammalian CPSF and CstF appear to as-
sociate with the carboxy-terminal domain of the RNA
polymerase II large subunit to couple transcription and
RNAprocessing (Dantonel et al+, 1997; McCracken et al+,
1997a, 1997b) and yeast cleavage factors were shown
to direct transcription termination (Birse et al+, 1998)+
Cleavage/polyadenylation sites have also been re-
ported to stimulate splicing (Niwa & Berget, 1991; Gun-
derson et al+, 1997) and it has been hypothesized that
this stimulation could involve interaction between PAP
and a still unknown splicing factor (Gunderson et al+,
1997), an interaction that may be favored by weak bind-
ing of U1 snRNP to the substrate in the vicinity of the
future 39 end (Wassarman & Steitz, 1993)+ Recipro-
cally, a number of in vitro and in vivo studies have
shown that splicing influences 39-end processing (Niwa
et al+, 1990; Nesic et al+, 1993; Wassarman & Steitz,
1993; Nesic & Maquat, 1994; Cooke & Allwine, 1996;
Liu & Mertz, 1996; Antoniou et al+, 1998; Baurén et al+,
1998; Dye & Proudfoot, 1999), and that splicing factors
interact with 39-end processing factors+ For example,
the U1A protein of U1 snRNP stimulates polyadenyla-
tion of the SV40 late pre-mRNA via a direct interaction
with the 160-kDa subunit of CPSF (Lutz et al+, 1996)+
There are also several well-understood examples of
inhibitory effects of splicing factors on 39-end forma-
tion+ The U1A protein bound to its own pre-mRNA in-
teracts with PAP to inhibit polyadenylation (Boelens
et al+, 1993; Gunderson et al+, 1994)+ In the HIV-1 pre-
mRNA, binding of U1 snRNP to the major splice donor
site inhibits 39-end formation at the cleavage and poly-
adenylation site located upstream of the donor site in
the 59 LTR of the HIV-1 provirus (Ashe et al+, 1995,
1997)+ In the bovine papilloma virus (BPV) late pre-
mRNA, U1 snRNP binding to a 59 splice site located
upstream of the major site of 39-end formation late in
infection inhibits use of this site early after infection
(Furth & Baker, 1991; Furth et al+, 1994)+ The mecha-
nism in this case involves inhibition of the polyadenyl-
ation activity of PAP via direct interaction with the U1
70K protein of U1 snRNP (Gunderson et al+, 1998)+ The
HIV-1 and BPV examples are striking because they
both involve the inhibition of 39-end processing by U1
snRNP binding in the vicinity of a cleavage/polyadenyl-
ation site+ However, the way U1 snRNP inhibits cleav-
age/polyadenylation in these two viruses is predicted
to be different on the basis of the biological function of
the regulatory process in each case+ In BPV, the goal is
to prevent accumulation of late mRNAs during early
infection in spite of the fact that their precursors are
being constantly transcribed+ Inhibition of polyadenyl-
ation ensures that 39-end cleaved, unstable RNAs are
produced from the BPV late genes that are destined to
be rapidly degraded+ If cleavage was inhibited instead,
the transcriptional readthrough products might be sta-
bilized by the use of downstream 39-end formation sites+
The function of the inhibition of pre-mRNA cleavage in
the HIV-1 59 LTR is to allow transcriptional readthrough
of the provirus+ To produce viral mRNAs, as well as
genomic RNAs, 39-end formation must occur in the 39
LTR and not in the 59 LTR+ If inhibition of 39-end for-
mation in the 59 LTR were at the polyadenylation step,
cleavage would take place and full-length viral pre-
mRNA would still not be produced+ This suggested that
in HIV-1, the cleavage step should be targeted for in-
hibition, and not the polyadenylation step+
One obvious difference between the two systems is
the position of U1 snRNP binding relative to the pro-
spective site of 39-end formation+ We therefore exam-
ined whether the position of U1 snRNP binding relative
to this site influenced the mechanism of inhibition of
39-end formation+ U1 snRNP binding to a 59 splice site
located downstream, rather than upstream,ofa cleavage/
polyadenylation site, is shown to affect cleavage rather
than polyadenylation in vitro+ Cleavage inhibition is not
mediated by the PAP-U1 70K interaction that is re-
quired for inhibition of polyadenylation+ Therefore, the
relative positions on the pre-mRNA of U1 snRNP and
the 39-end processing factors appears to determine
which interactions between the two complexes occurs,
which in turn determines the mechanism of inhibition of
39-end formation+
RESULTS
A 59 splice site inhibits endonucleolytic
cleavage at an upstream cleavage/
polyadenylation site in HeLa
nuclear extracts
To analyze the mechanism of HIV-1 poly(A) site inhi-
bition by U1 snRNP observed in vivo (Ashe et al+, 1995,
1997), we tried to establish in vitro cleavage assays in
HeLa nuclear extracts that would recapitulate the reg-
ulation+ However, previous studies have shown that the
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HIV-1 poly(A) site is almost completely inactive in cell-
free systems in the absence of activating sequences
(Gilmartin et al+, 1992; Valsamakis et al+, 1992)+ As
these sequences are not present in the context of the
59 LTR poly(A) site, and because it was not expected
from the work of Ashe et al+ (1995) that the effects of
U1 snRNP would be pre-mRNA-specific, we decided to
utilize instead the well-characterized Adenovirus L3
cleavage and polyadenylation site+ Pre-mRNA sub-
strates were constructed in which a wild-type or a mu-
tated 59 splice site was inserted either 13, 52, or 68 nt
downstream of an Adenovirus L3 cleavage/polyadenyl-
ation site (Fig+ 1A)+ In all cases the wild-type 59 splice
site was AAG/GUAAGU and the mutant sequence AAG/
caAAcU+ In BPV, U1 snRNP binding upstream of the
cleavage/polyadenylation site inhibits the polyadenyl-
ation step of 39-end processing (Gunderson et al+, 1998)+
To test whether U1 snRNP, when bound upstream of
the cleavage/polyadenylation site, could also affect
cleavage, pre-mRNA substrates were also utilized with
a wild-type or mutant 59 splice site positioned 7 nt up-
stream of the Adenovirus L3 cleavage/polyadenylation
site (Gunderson et al+, 1998; Fig+ 1A)+
Cleavage reactions in HeLa cell nuclear extracts were
performed and showed that maximally 10–15% of the
substrate RNAs were cleaved+ Cleavage of the parent
construct, AdL3, is shown in lanes 13 and 14 of Fig-
ure 1B+ The cleavage efficiencies of the substrates con-
taining a wild-type 59 splice site downstream of the
cleavage site were consistently three to six times lower
than the cleavage efficiencies of the corresponding sub-
strates with the mutant 59 splice site (Fig+ 1B; lanes 1–9)+
Inhibition was seen in all three constructs where the 59
splice site was inserted in a downstream position rel-
ative to the cleavage site+ This assay therefore reca-
pitulates in vitro the inhibitory effect of the 59 splice site
FIGURE 1. A 59 splice site located downstream of a cleavage/polyadenylation site inhibits the cleavage step of 39-end
processing in HeLa cell nuclear extract+ A: Scheme of the pre-mRNA substrates used+ They contain the wild-type Adeno-
virus L3 cleavage/polyadenylation site (AAUAAA) either alone (AdL3) or with a wild-type (AAGGUAAGU) or a mutant
(AAGcaAAcU) 59 splice site (59SS or slashed 59SS, respectively) at various distances around the cleavage/polyadenylation
site (the cleavage site is represented by an arrow)+ B: Effect of the presence of the 59 splice site on cleavage of the
pre-mRNAs in HeLa cell nuclear extract+ Lanes 1, 4, 7, 10, and 13 were the input substrates incubated in complete reaction
buffer without HeLa nuclear extract (Nxt), whereas lanes 2, 3, 5, 6, 8, 9, 11, 12, and 14 contained nuclear extract+ After
completion of the reaction, the RNAs were analyzed on a 10% denaturing polyacrylamide gel+ The precursors are indicated
with arrows, the 59 cleavage product with asterisks and unspecific degradation products in lane 10 with #+
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predicted from the in vivo observations on the HIV-1 59
LTR poly(A) site+ No effect of a 59 splice site inserted
upstream of the cleavage site in the -7S substrate was
observed (Fig+1B; lanes 10–12), consistent with the
previous conclusion that U1 snRNP mediates inhibition
of polyadenylation, but not cleavage, in both this sub-
strate (see below) and in the BPV pre-mRNA (Gunder-
son et al+, 1998)+
U1 snRNP inhibits 39-end cleavage
To demonstrate that U1 snRNP binding to the 59 splice
site was responsible for the inhibitory effect on cleav-
age, the extract was pretreated with a U1-specific DNA
oligonucleotide complementary to the 59 end of U1
snRNA prior to the cleavage reaction+ By virtue of the
RNAse H present in the extract, the RNA strand of
the RNA:DNA hybrid formed between the 59 end of U1
snRNA and the U1 oligonucleotide was efficiently de-
graded, as determined by Northern blot (data not
shown)+ The truncated U1 snRNA is unable to interact
with the 59 splice site (Krämer & Keller, 1990)+ For rea-
sons that are not understood, addition of the U1 oligo-
nucleotide increased the recovery of RNA from the
extracts+ However, when the proportion of cleaved RNA
was measured, the efficiency of cleavage of the 13S
substrate, with the wild-type 59 splice site, was in-
creased by fivefold (Fig+ 2A,B; compare lanes 8 and 9
with 7)+ Similar results were observed with the sub-
strates in which the 59 splice site was located 52 or
68 nt downstream of the cleavage site (data not shown)+
No comparable effect was observed on cleavage of the
control substrate with the mutant 59 splice site (Fig+ 2A,B;
lanes 2–4) or with the -7S substrate (Fig+ 2D, lanes 4
and 5)+ A further control, pretreatment of the extract
with a DNA oligonucleotide directed against U2 snRNP,
also had little effect on the cleavage efficiencies of the
substrates with either the wild-type or mutated 59 splice
site (Fig+ 2A,B: lanes 5 and 10; Fig+ 2D, lane 3)+ To
demonstrate that the lack of effect of U1 snRNP in the
case of the -7S substrate is not due to its inability to
bind to the 59 splice site on this RNA, we verified that
depletion of U1 snRNP but not U2 snRNP stimulates
the polyadenylation activity on the -7S pre-mRNA, con-
sistent with previous observations (Fig+ 2C, lanes 2, 4,
5; Gunderson et al+, 1998)+ We conclude that U1 snRNP
FIGURE 2. U1 snRNP mediates cleavage inhibition+ A: Prior to the
addition of the labeled pre-mRNA substrates, the nuclear extract was
pretreated with either 50 ng (lanes 3 and 8) or 200 ng (lanes 4, 5, 9,
and 10) of oligonucleotides complementary to U1 or U2 snRNAs as
indicated+ Lanes 2 and 7 were mock treated in the absence of added
oligonucleotide+ Lanes 1 and 6 were the input substrates+ The pre-
cursors are indicated with arrows and the 59 cleavage product with
asterisks+ B: Histogram of the cleavage activities+ Percentages of
cleavage were calculated by dividing the amount of cleavage product
by the sum of cleavage product and precursor and multiplying by
100+ The value for the cleavage fragment was corrected for the
different uridine contents of precursor and product+ C: Polyadenyla-
tion reactions in HeLa nuclear extracts+ Reactions were performed
as for cleavage except that 39 dATP was replaced by ATP+ Prior to the
addition of the labeled -7S pre-mRNA substrate, the nuclear extract
was pretreated with either 40 ng (lane 4) or 120 ng (lanes 3 and 5)
of oligonucleotides complementary to U1 or U2 snRNAs as indi-
cated+ Lane 2 was mock treated in the absence of added oligonu-
cleotide+ Lane 1: input substrate+ D: As in A but with the -7S substrate+
U1 snRNP effect on pre-mRNA 39 end cleavage 181
binding to a 59 splice site downstream of the cleavage/
polyadenylation site inhibits the cleavage step, whereas
its binding upstream inhibits polyadenylation+
U1 snRNP inhibition in a reconstituted
cleavage assay
A reconstituted cleavage assay can be performed by
recombining purified fractions containing the various
cleavage factors (Rüegsegger et al+, 1996; see Mate-
rials and Methods)+ These fractions do not contain U1
snRNP (data not shown), providing a direct way to test
the inhibitory effect of highly purified U1 snRNP on
cleavage+ Incubation of the various pre-mRNAs in this
assay led to cleavage efficiencies of roughly 10% (Fig+ 3;
lanes 2, 7, 12)+ Addition of purified U1 snRNP to the
reaction dramatically decreased the cleavage efficiency
of the 13S RNA substrate (Fig+ 3; lanes 3–5)+ This
inhibitory effect was specific, as cleavage of the mutant
control 13M substrate was not affected (Fig+ 3; lanes 8–
10), nor was cleavage of the -7S RNA substrate, which
has a wild-type 59 splice site located 18 nt upstream of
the cleavage site (Fig+ 3; lanes 12–14)+ As highly puri-
fied cleavage components and U1 snRNP were used,
the inhibitory effect of U1 snRNP on 13S cleavage
appears to be due to a direct effect of the snRNP on the
39 cleavage factors+
U1 snRNP does not impair the binding
of characterized cleavage factors
The simplest hypothesis to explain the observed inhi-
bition was that U1 snRNP binding to the RNA down-
stream of the 39 cleavage site would somehow impair
the correct assembly of cleavage factors on the pre-
mRNA+ To test this, we first analyzed the binding of the
64-kDa subunit of CstF+ Because CstF and CPSF bind
cooperatively to pre-mRNA and form a stable ternary
complex (see Introduction), the AAUAAA-dependent
binding of the 64-kDa subunit of CstF to the pre-mRNA
reflects the presence of these two factors+ UV cross-
linking experiments were performed with RNAs con-
taining either a wild-type or a mutant Adenovirus L3
cleavage/polyadenylation site without a 59 splice site
(Fig+ 4A; AAUAAA and AAGAAA, respectively) as well
as with substrates derived from the AAUAAA construct
with either a mutant or a wild-type 59 splice site, the
13M and 13S RNAs respectively+ The complex cross-
linking patterns in HeLa nuclear extracts (Fig+ 4A;
lanes 1, 4, 7, and 10) were resolved by immunoprecip-
itation with a monoclonal antibody directed against CstF
64 (MacDonald et al+, 1994) (Fig+ 4; lanes 3, 6, 9, and
12)+ CstF 64 was bound to the RNA containing the
wild-type but not the mutant cleavage/polyadenylation
site (Fig+ 4; lanes 3 and 6), showing that CPSF-
dependent and therefore specific CstF 64 binding was
measured+ The presence of a 59 splice site did not
affect CstF 64 binding (Fig+ 4, lanes 9 and 12)+ Thus,
U1 snRNP does not inhibit cleavage by impairment of
CstF, and by implication CPSF, binding to the pre-mRNA+
To test whether binding of CF Im was inhibited by U1
snRNP, UV crosslinking experiments were performed
on the 13S and 13M RNAs incubated with purified cleav-
age factors+ As shown previously (Rüegsegger et al+,
1996), all three polypeptides of CF Im can be UV cross-
linked to a pre-mRNA carrying a cleavage/polyadenyl-
ation site (Fig+ 4B, lanes 1 and 2)+Addition of U1 snRNP
to the 13S RNA substrate did not lead to a decrease in
CF Im crosslinking (Fig+ 4B; lane 3)+ Thus U1 snRNP
did not impair the binding of CF Im subunits to the
RNA+
The remaining well-characterized factor required for
the cleavage of some pre-mRNAs is PAP+ PAP alone
does not bind specifically to RNA but is tethered to
poly(A) sites by binding to the 160-kDa subunit of CPSF
(Murthy & Manley, 1995)+ To test PAP assembly into
the cleavage complex, pre-mRNAs were incubated in
cleavage extracts+ Immunoprecipitation was then car-
ried out with a polyclonal antibody directed against PAP
and the immunoprecipitated 32P-labeled RNA was vi-
sualized after gel electrophoresis+ To control the spec-
ificity of precipitation, substrate R1 carrying a wild-type
or mutant 59 splice site was precipitated with antibodies
directed against PAP in the presence of RNA R2 con-
taining AAUAAA (R2-U) or AAGAAA (R2-G)+ R2-U was
more efficiently precipitated than R1 for unknown rea-
sons (Fig+ 5, lane 3), but the mutation of the poly(A)
signal in R2 clearly led to preferential precipitation of
R1 (Fig+ 5, lane 4) showing that PAP was bound spe-
cifically to the poly(A) site+ Next, the influence of the
presence of a downstream 59 splice site on the recruit-
ment of PAP was tested+ No detectable difference be-
FIGURE 3. Purified U1 snRNP inhibits the cleavage step in a re-
constituted cleavage assay+ Reconstitution assays were performed
as described previously (Rüegsegger et al+, 1996)+ Lanes 1, 6, and
11 were the input substrates+ The different pre-mRNAs were incu-
bated in the absence (lanes 1, 2, 6, 7, 11, and 12) or in the presence
of increasing amounts (50, 100, or 200 ng) of purified U1 snRNP
(lanes 3–5, 8–10, 13, and 14)+ The precursors are indicated with
arrows and the 59 cleavage product with asterisks+
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tween immunoprecipitation of the wild-type (R1-13S)
and mutant (R1-13M) 59 splice site-containing RNAs
was observed (Fig+ 5, compare lanes 5 and 6)+ Finally,
anti-U1A antibody precipitated preferentially the R1-
13S RNA containing the 59 splice site (Fig+ 5, lanes 7–
10), showing that U1 snRNP was efficiently bound to
this RNA but did not affect PAP recruitment, and that
U1 snRNP did not bind to the mutant 59 splice site in
the control pre-mRNA+
Taken together, these experiments show that the U1
snRNP-mediated inhibition of cleavage does not occur
by impairment of the binding of the CPSF-CstF, CF Im,
or PAP+ The binding of all factors involved in cleavage
with the exception of CF IIm, for which no specific de-
tection methods are currently available, was therefore
unaffected by U1 snRNP+
The PAP-U1 70K interaction is
not involved in cleavage inhibition
In BPV, U1 snRNP binding to the 59 splice site up-
stream of the cleavage/polyadenylation site results in
inhibition of polyadenylation via a direct interaction be-
tween the U1 70K protein of U1 snRNP and PAP (Gun-
derson et al+, 1998)+ It was therefore of interest to test
the involvement of this interaction on U1 snRNP-
mediated cleavage inhibition+ The role of the domain of
PAP that interacts both with the U1 70K protein and
with a dimer of the U1A protein was investigated with a
mutant form of PAP from which the U1 70K interaction
region was deleted (PAP D695–739; Gunderson et al+,
1998)+ In the reconstituted cleavage assay this muta-
tion had no effect on the ability of U1 snRNP to mediate
cleavage inhibition on the 13S RNA substrate, where
the 59 splice site is located 13 nt downstream of the
cleavage site (Fig+ 6B; lanes 2–4)+ The possibility of a
contamination by wild-type PAP in the purified cleav-
age factors used in the assay was ruled out by dem-
onstrating that cleavage did not occur without additional
PAP (Fig+ 6A, compare lanes 2 and 3)+ Thus, PAP-U1
70K interaction is not necessary for U1 snRNP-mediated
inhibition of cleavage+
FIGURE 4. U1 snRNP does not impair the binding of CstF 64 or the CF Im subunits to the RNA+ A: UV crosslinking/
immunoprecipitation experiment with the 64-kDa subunit of CstF+ wild-type (AAUAAA) or mutant (AAGAAA) Adenovirus L3
cleavage/polyadenylation site-containing pre-mRNAs (lanes 1–6) or the pre-mRNAs described in Figure 1 (lanes 7–12)
were incubated in HeLa cell nuclear extract, crosslinked by UV irradiation, and crosslinked polypeptides were immunopre-
cipitated using the 3A7 monoclonal antibody directed against the 64-kDa subunit of CstF+ Five percent of the crosslinked
sample before immunoprecipitation (T) and the full supernatant (S) and pellet (P) fractions after immunoprecipitation were
resolved by 10% SDS-PAGE+ Protein markers are indicated on the left+ B: UV crosslinking experiment with CF Im+ The
different RNA substrates were incubated with the purified cleavage/polyadenylation components (as in Fig+ 3) in the
absence (lanes 1–2) or the presence (lane 3) of 200 ng purified U1 snRNP, crosslinked by UV irradiation, and loaded on a
10% SDS-PAGE gel+ The position and nature of the crosslinked proteins (64-kDa subunit of CstF and the 68-, 59-, and
25-kDa subunits of CF Im) are shown on the left, protein markers on the right+
FIGURE 5. Poly(A) polymerase (PAP) recruitment is unaffected by
a 59 splice site+ Wild-type (U) or mutant (G) Adenovirus L3 cleavage/
polyadenylation site containing pre-mRNA and the substrates de-
scribed in Figure 1 were incubated in HeLa cell nuclear extract for
2 min under cleavage conditions+ Mock immunoprecipitation (lanes 1,
2, 7, and 8) or immunoprecipitation with a polyclonal anti-PAP anti-
body (lanes 3–6) or a polyclonal anti-U1A antibody (lanes 9–10) was
performed+ The pellets were fractionated by 10% SDS-PAGE and
autoradiographed+
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The U1A and U1 70K proteins are not sufficient
for U1 snRNP-mediated inhibition of cleavage
Although not involved in an interaction with PAP, the U1
70K or the U1A proteins could interact with other cleav-
age factors to mediate the inhibition of cleavage+ To
test this possibility, we performed reconstituted cleav-
age reactions with a partly reconstituted U1 snRNP
consisting of an in vitro-transcribed modified U1 snRNA
and recombinant U1A and U1 70K proteins (Gunder-
son et al+, 1998)+ Because of the poor efficiency of
binding of U1 snRNA to a 59 splice site-containing RNA,
a modified U1 snRNA is used (U1 snRNA*) with an
extended 59 end that allows “prosthetic” base pairing to
an extended 59 splice site (Gunderson et al+, 1998)+
The 68S pre-mRNA substrate RNA (Fig+ 1) contains
this extended complementarity to U1 snRNA*+A U1A-U1
snRNA*, a U1 70K-U1 snRNA*, and a U1A-U1 70K-U1
snRNA* complex were preassembled (Gunderson et al+,
1998) and each was added separately to the 68S pre-
mRNA substrate+ Purified cleavage components were
then added to the different complexes+ No inhibition of
cleavage was observed in any case (Fig+ 7)+ Native gel
electrophoresis confirmed that U1 snRNA*-13S pre-
mRNA complexes were correctly assembled in each
case and addition of the U1 70K-containing RNPs in-
hibited polyadenylation of BPV pre-mRNA as previ-
ously shown (data not shown; Gunderson et al+, 1998)+
Therefore, unlike previous cases of 39-end formation
inhibition, the U1A and U1 70K proteins are not suffi-
cient for the U1 snRNP-mediated inhibition of cleavage
at an upstream site+ This indicates that the molecular
interactions involved in cleavage inhibition and in poly-
adenylation inhibition by U1 snRNP are different+
DISCUSSION
The results presented in this study reveal that U1 snRNP
can act in two mechanistically quite diverse ways to
FIGURE 6. The PAP-U1 70K interaction is not in-
volved in U1 snRNP-mediated inhibition of cleav-
age+ Reconstituted cleavage assays in the presence
of purified cleavage/polyadenylation components
(Rüegsegger et al+, 1996)+ Cleavage assays are as
in Figure 3, except that a mutant of PAP (PAP D695–
739) produced in E. coli was used in place of wild-
type PAP+ A: The 13M pre-mRNA was incubated
with all the purified cleavage factors (CF) neces-
sary for the reconstituted cleavage assay without
(lane 2) or with (lane 3) PAP D695–739+ Lane 1:
input substrate+ B: The 13S or 13M pre-mRNAs
were incubated with cleavage factors in the ab-
sence (lanes 1, 2, 5, and 6) or in the presence of
increasing amounts (100 or 200 ng) of purified U1
snRNP (lanes 3, 4, 7, and 8)+ Lanes 1 and 5: input
substrates+ The precursors are indicated with ar-
rows and the 59 cleavage product with asterisks+
FIGURE 7. The U1A and U1 70K proteins of U1 snRNP are not
sufficient for U1 snRNP-mediated cleavage inhibition+ Reconstituted
cleavage assays with the 68S pre-mRNA and with reconstituted U1
snRNP containing a modified U1 snRNA (U1 snRNA*) which forms
an extended base pairing interaction with the 68S pre-mRNA 59 splice
site region+ U1 snRNA* was added either alone (lane 3) or after
preassembly with recombinant U1A (lane 4), U1 70K (lane 5), or both
U1A and U1 70K proteins (lane 6)+ Lane 1 is the input substrate+
Lane 2 contains all the cleavage components but no reconstituted
U1 snRNP+ *59 and *39 are the 59 and 39 cleavage products, respec-
tively+ The precursor is indicated with an arrow+
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inhibit 39-end processing of pre-mRNAs+ In vitro cleav-
age reactions in HeLa cell nuclear extract and recon-
stituted cleavage assays were used to show that U1
snRNP binding to a 59 splice site located downstream
of the signals directing cleavage and polyadenylation
inhibits the first step of the reaction, 39-end cleavage+
Previous work had shown that binding of U1 snRNP to
a 59 splice site upstream of the same signals, in con-
trast, inhibited the polyadenylation step of 39-end pro-
cessing (Gunderson et al+, 1998)+ Whereas the latter
reaction required a specific interaction between the U1
70K protein of U1 snRNP and poly(A) polymerase, this
interaction is not sufficient for the inhibition of cleavage
by U1 snRNP+ Because removal of the U1 70K inter-
action domain from PAP does not affect the inhibition of
cleavage by U1 snRNP, it further seems that the pre-
viously characterized interactions between U1 70K, U1A,
and PAP are not involved in cleavage inhibition+
Mechanism of cleavage inhibition
by U1 snRNP
The detailed mechanism by which U1 snRNP inhibits
cleavage remains to be determined+ Here, the main
difficulty is that although many, but not all (see Intro-
duction), of the components required for 39-end cleav-
age have been identified, not much is known about the
mechanism by which cleavage occurs+ Cleavage re-
quires a large number of proteins that assemble into a
complex on the cleavage/polyadenylation site+ An un-
derstanding of how the different protein partners are
arranged at the cleavage/polyadenylation site is emerg-
ing, but is as yet incomplete+ In addition, the protein or
complex of proteins that constitutes the active site of
the required endonuclease activity is not yet identified+
In principle, U1 snRNP could either block one or more
steps required for the correct assembly of the cleavage/
polyadenylation machinery or it could inhibit an enzy-
matic activity required for cleavage+ The data presented
here indicate that the assembly processes required for
binding of CPSF, CstF, CF Im, and PAP to the pre-
mRNA do not seem to be affected by U1 snRNP bind-
ing+ The inhibitory mechanism is therefore probably not
a simple steric hindrance and likely involves direct in-
teraction between U1 snRNP and one or more of the
cleavage factors+
Three separate interactions between U1 snRNP com-
ponents and the 39-end formation machinery have pre-
viously been described+ The U1A protein, independently
of U1 snRNP, is able to interact with the 160-kDa sub-
unit of CPSF, and this interaction has a stimulatory
effect on polyadenylation (Lutz et al+, 1996)+ Both the
U1A protein, this time as a dimer, and the U1 70K
protein as a monomer can interact with the extreme
C-terminal segment of PAP (Gunderson et al+, 1997,
1998)+ Both of these interactions inhibit PAP activity
and thus block polyadenylation+ The inhibition of cleav-
age by U1 snRNP does not seem to involve any of the
known interactions+ Moreover, although inhibition by a
direct interaction between U1 70K and the 68-kDa sub-
unit of CF Im via their SR-like domains seemed plausi-
ble (Theissen et al+, 1986; Rüegsegger et al+, 1998),
this interaction is certainly not sufficient for inhibition
(see Fig+ 7), as neither U1 70K or U1A alone or in
combination is sufficient to mediate the inhibitory effect
on cleavage+ Thus, the mechanism of inhibition could
involve the other U1 snRNP-specific protein, namely
the U1C protein or one of the Sm core proteins (Lühr-
mann et al+, 1990)+ Alternatively, a complex aspect of
U1 snRNP structure involving more than one of its com-
ponents could be required+
The inhibitory effect of U1 snRNP on cleavage is
expected to be general because it was observed with
different synthetic RNA substrates containing 59 splice
site insertions at various positions and in two different
sequence contexts+ The first indication of an inhibitory
effect of U1 snRNP on cleavage, strongly predicted to
involve a similar mechanism to that described here,
was observed in vivo with a different cleavage/poly-
adenylation site, that present in the 59 LTR of HIV-1,
and in that case inhibition was also observed in various
contexts (Ashe et al+, 1995, 1997)+ A requirement for a
certain distance between the sites of 39-end formation
and U1 snRNP binding or for a particular RNA struc-
ture in the pre-mRNA could exist, however+ Increasing
the distance between the 59 splice site and the cleav-
age site in HIV-1 pre-mRNA abolished the inhibitory
effect in vivo (Ashe et al+, 1997)+ This would suggest
that also in vivo, the U1 snRNP has to interact directly
with the cleavage/polyadenylation machinery+
The influence of relative position
on the inhibitory mechanism
When bound upstream of the cleavage/polyadenylation
site, U1 snRNP does not inhibit cleavage but instead,
through binding of the U1 70K protein of U1 snRNP to
PAP, inhibits polyadenylation (Gunderson et al+, 1998)+
Establishing why the snRNP is not capable of inhibiting
cleavage from this position will obviously require a much
more detailed knowledge of the structure formed by the
cleavage and polyadenylation factors when they bind
to an RNA+ However, the two inhibitory mechanisms
have quite different requirements, indicating that they
probably evolved separately+ U1 snRNP bound to a site
downstream of the point of 39 cleavage may be re-
moved from the template for poly(A) addition immedi-
ately after 39 cleavage, and thus be incapable of
participating in the inhibition of polyadenylation even if
the U1 70K of this snRNP had been in contact with PAP
prior to the cleavage event+ The consequences of the
two types of inhibition are also quite different+ Inhibition
of the first step allows the accumulation of pre-mRNA
transcripts that read through a potential site of 39-end
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formation+ This is used by HIV-1 to ensure the produc-
tion of full length transcripts of its genome rather than
short RNAs truncated in the 59 LTR+ Clearly, the same
mechanism could be used to control the use of 39-end
formation sites in cellular pre-mRNAs, perhaps in a
regulated fashion+
An interesting further possibility is that this same
mechanism could operate generally in pre-mRNAs to
help prevent 39-end processing occurring in the 59 ter-
minal exon or in internal exons rather than in the 39-
terminal exon+ An AAUAAA sequence will occur every
4 kb on average, and this sequence can frequently be
found elsewhere than in 39 terminal exons+ How many
of these AAUAAA signals might potentially be recog-
nized by the 39-end formation apparatus is unclear,
mainly because the poor conservation of the down-
stream elements of sites of 39-end formation makes
them difficult to predict from DNA sequence data+ A
mechanism may therefore exist to inhibit the use of
cryptic cleavage/polyadenylation sites located in up-
stream exons+ As cleavage/polyadenylation sites
present in these exons will always be located upstream
of a 59 splice site, it could be that U1 snRNP binding
inhibits the use of any potential sites+ Only cleavage/
polyadenylation sites present in 39 terminal exons that
are not upstream of a nearby 59 splice site would then
be used+
The consequences of the second mode of inhibition,
that is, of U1 snRNP inhibiting the second step of 39-
end formation, are quite different+ Here, cleaved but
nonadenylated RNAs are produced+ These will presum-
ably be unstable+ Inhibiting polyadenylation but permit-
ting cleavage can therefore be used as an on/off switch
for particular genes, as exemplified both by the U1A
autoregulatory loop, where excess U1A protein switches
off the production of U1A mRNA, and the BPV case
where U1 snRNP prevents accumulation of late viral
mRNAs at early times in infection+ The quite different
logic behind the two forms of regulation of 39-end for-
mation by U1 snRNP further supports the hypothesis
that they probably evolved entirely separately+
Taken together, our observations underline the no-
tion that the splicing and the cleavage and poly-
adenylation processing machineries assembled on a
pre-mRNA influence each other+ With the in vitro re-
constituted system described here and further ad-
vances in understanding the mechanism of 39 cleavage,
it will be possible to address the detailed mechanism of
cleavage inhibition by U1 snRNP+
MATERIALS AND METHODS
Plasmid constructions
Plasmids were constructed by standard cloning procedures+
They are all pSP64 derivatives+ pSP-U (or AdL3) is the orig-
inal plasmid described in Boelens et al+ (1993)+ It contains
nt 22293–22600 of the Adenovirus L3 late region that in-
cludes the cleavage/polyadenylation site+ The first 60 nt are
derived from the pSP64 vector+ pSP-G was derived from
pSP-U and has an AAUAAA-to-AAGAAA mutation in the Ad-
enovirus L3 cleavage/polyadenylation signal+ pSP-7S was
constructed by inserting a wild-type 59 splice site sequence
18 nt upstream of the cleavage site (Gunderson et al+, 1998)+
pSP-7M was derived from pSP-7S by an AAGGTAAGT-
to-AAGCAAACT mutation in the 59 splice site sequence+
The critical sequence region in -7S is GAATTCCAGGTAA
GTAGTTATCAAUAAA and in -7M GAATTCCAGCAAACT
AGTTATCAAUAAA+ pSP13S and pSP52S were constructed
by insertion of the 59 splice site sequence 13 or 52 nt down-
stream of the cleavage site+ The mutant 59 splice site was
incorporated into the pSP13M and pSP52M plasmids+ pSP68S
and pSP68M were constructed by insertion of a sequence
(CGTAAATGTAAAACAGAAGGTAAGT) corresponding to a
59 splice site with an extended potential base pairing with the
prosthetic U1 snRNA* described in Gunderson et al+ (1998)




The wild-type and mutant (D695–739) PAP proteins with a
carboxy-terminal histidine tag were produced in Escherichia
coli and purified by Ni21-NTA chromatography (Gunderson
et al+, 1997)+ The human U1A protein was purified from E. coli
(Gunderson et al+, 1994)+ The C-terminally His-tagged human
70K protein was expressed in Sf9 cells using the Bac-to-Bac
expression kit (Gibco-BRL) and purified as described in Gun-
derson et al+ (1998)+
Purification of U1 snRNP
U1 snRNP was purified using an adaptation of the procedure
described by Bach et al+ (1990)+ Thirty milliliters of buffer 1
(20 mM HEPES, pH 7+9, 420 mM NaCl, 1+5 mM MgCl2, 0+2 mM
EDTA) were added to 20 mL of HeLa nuclear extract (200 mg
protein)+ The material was filtered (0+45 mM) and slowly
(3 mL/h) loaded onto a 1-mL TMG cap antibody column
(Oncogene Science) that had been equilibrated in buffer B
(buffer A 1 10% glycerol)+ The unbound material was col-
lected and the column washed with buffer B+ The material
bound to the TMG column (total snRNP particles, i+e+, U1, U2,
U4, U5, U6) was eluted by soaking the column overnight in
buffer B 1 15 mM 7-methylguanosine (Sigma)+ The eluate
was applied to a MonoQ column using running buffer C (20 mM
Tris, pH 7+9, 1+5 mM MgCl2, 0+5 mM DTT)+ A linear gradient
from 0 to 600 mM KCl resulted in highly purified U1 snRNP
fractions eluting around 350 mM KCl+
Cleavage/polyadenylation reactions
in HeLa nuclear extracts
Nuclear extracts were prepared from HeLa cells by the pro-
cedure of Dignam et al+ (1983)+ Substrate RNAs were tran-
scribed by SP6 RNA polymerase and m7GpppG capped+ In
vitro reactions in HeLa cell nuclear extracts were as de-
186 S. Vagner et al.
scribed (Boelens et al+, 1993)+ Oligonucleotide-mediated
RNAse H digestion of U1 snRNP and U2 snRNP was achieved
by addition of DNA oligonucleotides complementary to nt
1–14 of U1 snRNA or 40–70 of U2 snRNA to HeLa nuclear
extract (Krämer & Keller, 1990)+ After a 15-min incubation,
the labeled substrate was then added and the reaction was
continued for 120 min+ Reconstituted cleavage reactions were
performed as described in Rüegsegger et al+ (1996) with
additions as described in the text+
UV crosslinking/immunoprecipitation
HeLa cell nuclear extract was incubated for 5 min with 32P-
labeled RNAs under cleavage conditions+ The reaction mix-
tures were then irradiated with UV light (254 nm) in a
Stratalinker (Stratagene) at 0+4 J/cm2 on ice at a distance of
10 cm from the lamps+ Fifty units of RNAse T1 were then
added and the reaction mixtures were incubated for 30 min at
37 8C+ SDS gel loading buffer was added and the samples
were boiled for 2 min before they were fractionated on a 10%
SDS-polyacrylamide gel+ For immunoprecipitation of UV cross-
linked proteins, 20 mL of the RNAse T1-treated samples were
diluted in 200 mL of IP2 buffer (50 mM Tris-HCl, pH 7+5,
50 mM NaCl, 0+05% NP-40), precleared, and mixed with 7 mL
of anti-CstF 64 monoclonal antibody (MacDonald et al+, 1994)+
The mixtures were allowed to rotate 1 h at 4 8C+ Protein G
beads were added to the mixtures and incubations continued
for 1 h at 4 8C+ After extensive washing of the beads, the
bound proteins were eluted in SDS-loading buffer+
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